Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
-
501
-
502
-
503
-
504
-
505
-
506
-
507
Fli-1 directly activates miR-17-92 promoter and contributes to miR-17 and miR-20a expression in NN10#5 cells.
Published 2012“…C: ChIP analyses performed in NN10#5 cells using Fli-1 or control UBC9 antibodies followed by q-PCR of miR-17-92 promoter and GAPDH or 129k negative control regions. …”
-
508
-
509
-
510
-
511
-
512
-
513
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
514
-
515
Hedgehog signaling is decreased in <i>Foxa1</i>;<i>Foxa2</i> double knockouts.
Published 2013“…At E9.5, <i>Shh</i> mRNA is found in the brain, midline, and hindgut of control (A) <i>Foxa1</i> null (B) and <i>Foxa2</i> knockout embryos (C). …”
-
516
-
517
-
518
-
519
-
520
Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study
Published 2014“…<div><p>Background</p><p>A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). …”